BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24556721)

  • 1. RNA editome imbalance in hepatocellular carcinoma.
    Qi L; Chan TH; Tenen DG; Chen L
    Cancer Res; 2014 Mar; 74(5):1301-6. PubMed ID: 24556721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine-to-inosine RNA editing meets cancer.
    Dominissini D; Moshitch-Moshkovitz S; Amariglio N; Rechavi G
    Carcinogenesis; 2011 Nov; 32(11):1569-77. PubMed ID: 21715563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
    Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: transcriptome diversity regulated by RNA editing.
    Li Y; Chen L; Chan TH; Guan XY
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1843-8. PubMed ID: 23748106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine-to-Inosine RNA Editing in Health and Disease.
    Gatsiou A; Vlachogiannis N; Lunella FF; Sachse M; Stellos K
    Antioxid Redox Signal; 2018 Sep; 29(9):846-863. PubMed ID: 28762759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis.
    Song Y; An O; Ren X; Chan THM; Tay DJT; Tang SJ; Han J; Hong H; Ng VHE; Ke X; Shen H; Pitcheshwar P; Lin JS; Leong KW; Molias FB; Yang H; Kappei D; Chen L
    J Hepatol; 2021 Jan; 74(1):135-147. PubMed ID: 32693003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide evaluation and discovery of vertebrate A-to-I RNA editing sites.
    Maas S; Godfried Sie CP; Stoev I; Dupuis DE; Latona J; Porman AM; Evans B; Rekawek P; Kluempers V; Mutter M; Gommans WM; Lopresti D
    Biochem Biophys Res Commun; 2011 Sep; 412(3):407-12. PubMed ID: 21835166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA editing by mammalian ADARs.
    Hogg M; Paro S; Keegan LP; O'Connell MA
    Adv Genet; 2011; 73():87-120. PubMed ID: 21310295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALU A-to-I RNA Editing: Millions of Sites and Many Open Questions.
    Schaffer AA; Levanon EY
    Methods Mol Biol; 2021; 2181():149-162. PubMed ID: 32729079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and Transcriptome-Wide Identification of A-to-I RNA Editing Sites by ICE-Seq.
    Okada S; Sakurai M; Ueda H; Suzuki T
    Methods Enzymol; 2015; 560():331-53. PubMed ID: 26253977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Analysis of A-to-I RNA Editing.
    Savva YA; Laurent GS; Reenan RA
    Methods Mol Biol; 2016; 1358():255-68. PubMed ID: 26463388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genomic and bioinformatic approaches for the identification of new adenosine-to-inosine substrates.
    Sixsmith J; Reenan RA
    Methods Enzymol; 2007; 424():245-64. PubMed ID: 17662844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.
    Chen L; Li Y; Lin CH; Chan TH; Chow RK; Song Y; Liu M; Yuan YF; Fu L; Kong KL; Qi L; Li Y; Zhang N; Tong AH; Kwong DL; Man K; Lo CM; Lok S; Tenen DG; Guan XY
    Nat Med; 2013 Feb; 19(2):209-16. PubMed ID: 23291631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of widespread ultra-edited human RNAs.
    Carmi S; Borukhov I; Levanon EY
    PLoS Genet; 2011 Oct; 7(10):e1002317. PubMed ID: 22028664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbing A-to-I RNA editing using genetics and homologous recombination.
    Staber CJ; Gell S; Jepson JE; Reenan RA
    Methods Mol Biol; 2011; 718():41-73. PubMed ID: 21370041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins.
    Mannion N; Arieti F; Gallo A; Keegan LP; O'Connell MA
    Biomolecules; 2015 Sep; 5(4):2338-62. PubMed ID: 26437436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer.
    Lee SH; Kim HP; Kang JK; Song SH; Han SW; Kim TY
    Cancer Res Treat; 2017 Oct; 49(4):1077-1087. PubMed ID: 28161934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics.
    Nakano M; Nakajima M
    Pharmacol Ther; 2018 Jan; 181():13-21. PubMed ID: 28716651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.